Pfizer and BioNTech Supplying 100 Million Additional Doses of Coronavirus Vaccine to European Union

1 min read

The European Union is opting to buy 100 million additional doses of Pfizer (NYSE: PFE) and BioNTech‘s (NASDAQ: BNTX) BNT162b2 vaccine, the two companies announced in a joint press release. This adds to the original 200 million dose order from the EU, a political and economic bloc of 27 countries on that continent.

“In partnership with the European Commission, member states, and healthcare providers, we will be able to reach a total of 150 million Europeans across the continent,” the companies wrote in their press release.

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Invesco Mortgage Capital Raises Dividend by 60%

Next Story

Is There a Limit to Charitable Giving for Taxes?

Latest from Blog